Xyosted 100 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FUEY1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,630
Award facts
- Contract value 100% obligated
- $1,629.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,629.66 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector supplies, with an ultimate completion date of October 16, 2025. This competitive award, issued on October 15, 2025, utilizes firm fixed pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive IDC vehicle. The parent contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The Defense Logistics Agency's Troop Support Medical supply chain relies on such contracts to provision the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for testosterone replacement therapy auto-injectors reflects the ongoing pharmaceutical supply needs of federal military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FUEY1?
SPE2DB26FUEY1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 15, 2025.
How much is contract SPE2DB26FUEY1 worth?
The government has obligated $1,630 on SPE2DB26FUEY1.
Is contract SPE2DB26FUEY1 an order under another contract?
Yes. SPE2DB26FUEY1 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB26FUEY1 competed?
The extent of competition for SPE2DB26FUEY1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award